Barinthus Biotherapeutics plc
BRNS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $47,611 | $141,644 | $87,533 | $413,170 |
| - Cash | $110,662 | $142,090 | $194,385 | $214,054 |
| + Debt | $12,007 | $12,976 | $8,773 | $7,222 |
| Enterprise Value | -$51,044 | $12,530 | -$98,079 | $206,338 |
| Revenue | $14,969 | $802 | $44,703 | $268 |
| % Growth | 1,766.5% | -98.2% | 16,580.2% | – |
| Gross Profit | $14,969 | $802 | $44,703 | $268 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$55,374 | -$71,065 | $5,192 | -$47,870 |
| % Margin | -369.9% | -8,861% | 11.6% | -17,861.9% |
| Net Income | -$61,074 | -$73,347 | $5,342 | -$50,865 |
| % Margin | -408% | -9,145.5% | 11.9% | -18,979.5% |
| EPS Diluted | -1.55 | -1.91 | 0.14 | -1.37 |
| % Growth | 18.8% | -1,464.3% | 110.2% | – |
| Operating Cash Flow | -$28,940 | -$50,925 | -$14,431 | -$32,583 |
| Capital Expenditures | -$892 | -$5,413 | -$6,138 | -$1,146 |
| Free Cash Flow | -$29,832 | -$56,338 | -$20,569 | -$33,729 |